Insidertrades

Replimune Group

REPL

Insider trades and stock quote 2024-2026

All insider trades at Replimune Group

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/10/2026 Sell Schwendenman, Andrew Chief Accounting Officer $13.0 $98,987
8/10/2026 Sell Xynos, Konstantinos Chief Medical Officer $13.0 $148,468
8/10/2026 Sell Hill, Emily Luisa Chief Financial Officer $13.0 $148,481
8/10/2026 Sell Patel, Sushil Chief Executive Officer $13.0 $510,253
6/1/2026 Sell Sarchi, Christopher Chief Commercial Officer $9.2 $110,880
5/18/2026 Sell Hill, Emily Luisa Chief Financial Officer $5.1 $39,685
5/18/2026 Sell Patel, Sushil Chief Executive Officer $5.1 $189,606
5/18/2026 Sell Astley-Sparke, Philip Director $5.1 $89,698
5/18/2026 Sell Sarchi, Christopher Chief Commercial Officer $5.1 $43,820
5/18/2026 Sell Schwendenman, Andrew Chief Accounting Officer $5.1 $40,102
5/18/2026 Sell Xynos, Konstantinos Chief Medical Officer $5.1 $71,237
4/2/2026 Sell Sarchi, Christopher Chief Commercial Officer $8.0 $52,065
12/9/2025 Sell Dhingra, Kapil Director $10.4 $32,958
12/2/2025 Sell Patel, Sushil Chief Executive Officer $11.1 $111,300
11/17/2025 Sell Xynos, Konstantinos Chief Medical Officer $9.1 $65,957
11/17/2025 Sell Sarchi, Christopher Chief Commercial Officer $9.1 $47,393
8/15/2025 Sell Hill, Emily Luisa Chief Financial Officer $5.4 $49,157
5/20/2025 Sell Sarchi, Christopher Chief Commercial Officer $8.0 $30,179
5/20/2025 Sell Hill, Emily Luisa Chief Financial Officer $8.0 $20,407
5/20/2025 Sell Patel, Sushil Chief Executive Officer $8.1 $202,346
5/20/2025 Sell Schwendenman, Andrew Chief Accounting Officer $8.0 $26,460
5/20/2025 Sell Xynos, Konstantinos Chief Medical Officer $8.1 $64,093
5/20/2025 Sell Astley-Sparke, Philip Director $8.1 $260,169
12/16/2024 Sell Patel, Sushil Chief Executive Officer $12.4 $124,200
11/18/2024 Sell Sarchi, Christopher Chief Commercial Officer $10.8 $56,131
11/18/2024 Sell Xynos, Konstantinos Chief Medical Officer $10.8 $78,112
8/16/2024 Sell Hill, Emily Luisa Chief Financial Officer $10.2 $90,989
Rows per page:
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)